Subject Index

Previous   Next


A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   R   S   T   U   V   W   X   Y   Z  


Mahoganoid mutation    2.III.B.3, 2: notes 43, 44
Mahogany mutation    2.III.B.2; 2: note 42; 6.IV.L
Malpighian cells    2: note 23; 3: note 20; 4.I.D; 4: note 11
Maltese dilution mutation (see Dilute mutation)
Mammae, effect of MSH on    2: note 37
   of grey-lethal mice    5.I.A
   of lethal yellow mice    2: notes 20, 37
   of nonagouti mice    2.I.A.10; 2: note 21
   of sombre mice    2.II.A.1
   of taupe mice    6.IV.M
Mammalian spot test    12: note 32
Manganese    5.IV
   effect on otolith development    5.IV.D; 5: note 11
Maroon mutation    4.IV.B; 6: note 11
Mast cells, effect of W-locus on    10: note 27
   of beige mice    6: note 9
Maternal influence, on albinism    3: note 22
   on brindled    8: notes 7, 18
   on greying with age    6.III.A
   of lethal yellow    2.I.A.1
   on mosaic    8: note 7, 18
   on mottled agouti    2: note 9
   on viable yellow    2: note 9
Megacolon, in lethal spotting mice    9.III.A
   in piebald-lethal mice    9.II.B.1, 9.II.B.2, 9.II.G, 9.III.A; 9: note 5
   in piebald mice    9.II.A.3, 9.II.B.2, 9.II.G, 9.III.A, 9: note 5
   in piebald (pb) mice    9: note 6
Melanin (see Eumelanin, Phaeomelanin)
Melanin granule (see Melanosome)
Melanoblasts (see Melanocytes)
Melanocytes, absence in white spots    2.I.E, 3.I.G, 3.I.G.2, 3.II, 3.II.A; 3: note 10; 7.VII, 9.I; Figures 3-5, 3-10, 3-11
   in Chediak-Higashi syndrome    6: note 3
   incorporation into hair    3.I.G, 3.I.G.1, 4.I.D; Figures 3-3, 3-4, 3-5, 3-6, 3-7, 3-8, 4-2
   effect, of cellular environment on    2.I.E, 2.II.C.3, 2.II.D, 4.I.E, 9.II.G, 9.IV.B, 10.I.E, 11.I.D, 12.III; 12: note 12; Tables 2-4, 2-5, 2-6, 10-1, 11-2; Figure 4-5
      of MSH on    2.II.D; 2: notes 36, 37, 38; Figures 2-5, 2-6
      of sulfhydryls on    2.I.D
      of UV light on    1: note 3, 2: note 23, 3: note 20; 4.I.D; 4: note 11, 12
   nucleofugal    3.I.G.1, 4.I.D, 4.I.E, 5.I.A; Figures 3-8, 4-3, 4-4, 4-5
   nucleopetal    3.I.G, 3.I.G.1, 4.I.D, 4.I.E, 5.I.A; 5: note 1; Figures 3-8, 4-3, 4-4, 4-5
   number in zigzag hairs    2: note 25
   occurrence of    1: notes 3, 5; 9: note 17; 10.I.E; Table 10-1
   of agouti mice    2.I.C, 2.I.E, 2.II.C.3; 2: notes 21, 23, 25; Figure 2-3
   of albino mice    2.II.C.3, 3.I.G, 3.II, 3.II.A, 3.II.B; 3: note 12; 5.IV.A, 7.IV; 7: note 5; 10.I.D; 11: note 11; Figures 3-12, 3-13
   of allophenic mice (see Allophenic mice, Allophenic patterns)
   of ankle skin (see Skin)
   of beige mice    6.I.D, 6.I.E; 6: notes 3, 7; Figure 6-2
   of belted mice    9.IV.B; 9: note 16
   of brindled mice    8.II.C.2
   of brown versus black mice (see Brown mutation)
   of chickens    9: note 16
   of choroid (see Choroid)
   of dappled-2 females    8: note 4
   of dermis (see Dermis)
   of dilute mice    3.I.G.1, 4.I.D, 4.I.E; 4: note 12; Figures 4-2, 4-3, 4-5
   of dominant spotting mice    10.I.D
   of ear (see Ears, Membranous labyrinth)
   of "epidermal melanin units"    4: note 11
   of epidermis (see Epidermis)
   of feet (see Feet, Plantar skin)
   of genital papilla (see Genital papilla)
   of grey-lethal mice    5.I.A
   of hair follicles    1.I, 2.I.D; 2: notes 23, 25, 36, 37; 3.I.G, 3.I.G.1, 3.I.G.2, 3.II.A, 3: notes 6, 9, 10; 4.I.D, 4.II.E, 6.I.E; 8: note 4; 11: note 17; Figures 3-4, 3-5, 3-6, 3-7, 3-8, 3-12, 3-13, 4-2
   of harderian gland (see Harderian gland)
   of leaden mice    3.I.G.1, 4.I.D, 4.I.E; 4: note 11; Figure 4-2, 4-4, 4-5
   of leg muscles (see Leg muscles)
   of lethal yellow mice    2.II.C.3; 2: notes 20, 23, 37; 3.I.G, 3.I.G.1, 6.I.C; Figures 2-2, 4-3
   of light ear mice    6: note 17
   of light mice    3.I.G, 3.I.G.1; 3: note 9; Figures 3-3, 3-4, 3-5, 3-6, 3-7, 3-8, 3-9
   of meninges    2.II.C.2
   of microphthalmia mice    12.I.A.1
   of muzzle (see Nose)
   of newborn skin    1: note 3; 10.II.D
   of nonagouti mice    2.I.E; 2: notes 21, 23, 25, 36, 37; 3.I.G, 4.I.D, 4.I.E, 6.I.D; Figures 3-4, 3-5, 3-6, 3-8, 3-9, 4-2, 4-3, 4-4, 4-5
   of pallid mice    5.IV.B, 5.IV.D, 5: note 7
   of patch mice    10.II.D
   of PET mice    4: note 10
   of piebald mice    9.II.A.2, 9: notes 6, 11, 13, 14
   of pink-eyed dilution mice    3.I.G, 3.I.G.1, 4.II.E; Figure 4-2
   of rats    2: note 22
   of recessive yellow mice    2.II.C.2, 2.II.C.3
   of retina (see Retina)
   of ruby-eye mice    4.IV.B, 6.I.E
   of rump-white mice    10.II.D
   of scrotum (see Scrotum)
   of spinal cord    2.II.C.2
   of steel mice    9: note 16; 11.I.B, 11.I.D, 11.I.D.1, 11: notes 13, 15
   of tail (see Tail)
   of uvea    3.I.G.3
   of viable dominant spotting mice    9: note 16; 10.I.D, 10.I.E; 10: note 16
   origin of    1: note 5; 3.II.A, 4.II.C.9, 7.I, 7.III; Figure 3-13
   phenoclones of    7.VI, 8.II.D.1, 8.II.E.2, 8.II.F.1, 8.II.G.1, 8.II.H, 11.IV.A.2, 12.III
   reutilization in hair follicles    3.II.G.2; 11: note 17
   sensitivity to x-rays    3.II.A; 3: note 18
Melanocyte stimulating hormone (MSH)    2.II.D; 2: notes 36, 37, 38; Figures 2-5, 2-6
Melanophores    4.I.B
Melanosomes, attributes of    2.I.C, 3.I.C, 3.II.D, 4.II.D, 4.II.E, 6.I.D, 6.I.E; Tables 2-3, 3-4; Figures 2-2, 2-3, 4-6
   definition of    3: note 3
   effect, of b-locus on    3.I.C, 3.I.E, 3.I.F, 3.I.G, 3.II.D, 3.II.G; 3: notes 2, 5, 6, 8; 4.II.E, 6.I.E; Tables 2-3, 3-4; Figures 3-1, 4-2, 4-3, 4-4, 4-5, 4-6, 6-3
   of c-locus on    3.II.D, 3.II.G; 3: note 17; Table 3-4; Figure 4-6
   of MSH on    2.II.D; 2: note 36, 37, 38; Figures 2-5, 2-6
   in Chediak-Higashi syndrome    6.I, 6: note 3
   of albino mice    3.II.G, 6.I.E
   of agouti mice    2.I.C, 2.I.E; Figure 2-3
   of Ballantyne's spotting mice    10.I.I.2
   of beige mice    6.I.B, 6.I.C, 6.I.D; 6: notes 4, 7, 8; Figure 6-1
   of choroid    3: note 5; 4.I.C, 4.II.E, 5.IV.B, 6.I.D, 6.I.E; 6: notes 3, 7, 8; Figures 3-15, 3-16, 4-8, 6-2, 6-3
   of cordovan mice    3: note 6
   of dilute mice    4.I.B, 4.I.C, 4.I.D, 4.I.E; 4: notes 11, 12; Figures 4-2, 4-3, 4-5, 4-6
   of dominant spotting mice    10.I.C
   of "epidermal melanin unit"    4: note 11
   of grey-lethal mice    5.I.A, 5.II
   of grizzled mice    5.II.A
   of inner ear    5.IV.B; 5: notes 7, 8
   of iris    3: note 5
   of leaden mice    4.I.C, 4.I.D; Figures 4-1, 4-2, 4-4, 4-5
   of lethal yellow mice    2.I.C, 2.II.C.2, 3.II.D; 12: note 24; Table 3-4; Figures 2-2, 4-6
   of light ear mice    6.IV.I, 6: note 17
   of light mice    3.I.G; 3: note 8; Figures 3-3, 3-4, 3-5, 3-8
   of microphthalmia mice    12.I.D.2
   of microphthalmia-spotted mice    12.I.D.2; 12: notes 23, 24
   of mocha mice    5.III.A
   of nonagouti mice    3.I.E, 3.I.G, 3.I.G.1; 3: note 5; 4.I.C, 4.II.A, 5.IV.B; 5: note 8; 6.I.C, 6.I.D; Tables 2-3, 3-4; Figures 3-1, 3-3, 3-4, 3-5, 3-6, 3-7, 3-8, 3-9, 4-1, 4-2, 4-3, 4-4, 4-5, 4-6, 4-8, 6-1, 6-2, 6-3
   of pale ear mice    6.IV.I
   of pallid mice    5.IV.B, 5.IV.D; 5: note 7
   of pink-eyed dilution mice    3.II.G, 4.II.D, 4.II.E, 6.I.C, 6.I.E; 6: note 8; Figures 4-1, 4-2, 4-6, 4-7
   of platino mice    6: note 18
   of recessive yellow mice (see of lethal yellow mice)
   of retina    3.I.F, 3.II.G; 3: note 5; 4.I.C, 4.II.E, 4.III.B, 5.IV.B; 5: notes 7, 8; 6.I.D; 6: notes 3, 8; Figures 3-14, 3-15, 4-7, 4-8, 6-2, 6-3
   of ruby-eye mice    4.III.B; 4: note 20; 6.I.C, 6.I.E, Figures 3-1, 6-1
   of silver mice    6.II.B
   of viable dominant spotting mice    10.I.C
   of white mice    12.I.B.1, 12.I.D.2; 12: note 24
   ontogeny of    2.I.C, 3.I.D, 3.I.E, 3.II.G; 3: note 5; 4.II.E, 4.III, 4.III.B; 4: note 20; 5.IV.B, 6.I.D, 6.I.E; 6: notes 3, 7; Figures 2-2, 2-3, 3-14, 3-15, 3-16, 4-7, 6-2
   ultrastructure of    2.I.C, 3.I.E, 3.I.F, 3.I.G; 3: notes 4, 5, 7; 4.II.E, 4.III.B, 5.IV.B, 6.I.E; 6: notes 3, 4, 7; Table 2-3; Figures 2-2, 2-3, 3-1, 3-15, 3-16, 4-7, 6-3
Membranous labyrinth    9: note 17
   of belted mice    9.IV.B
   of lethal spotting mice    9.III.B; Table 9-2
   of nonagouti mice    Table 9-1
   of piebald mice    Table 9-1
   of steel mice    Table 11-2
   of steel-Dickie mice    Table 11-2
Meninges, melanocytes in    2.II.B.2
Menkes' kinky hair syndrome    8.II.I
Microphthalmia-brownish mutation (see also Microphthalmia locus)    12.I.F; Table 12-3
microphthalmia-Clinical Research Center mutation (see also Microphthalmia locus)
Microphthalmia locus    12.I; Tables 12-1, 12-2, 12-3; Figure 12-1
   alleles at    12.I.A, 12.I.B, 12.I.C, 12.I.D, 12.I.E, 12.I.F
      action of    12.I.A.1, 12.I.A.2, 12.I.B.3, 12.I.C.1; 12: notes 2, 4, 5, 9
      interaction of    12.I.B.4, 12.I.C, 12.I.D, 12.I.E, 12.I.F; 12: notes 2, 7, 16, 18, 22, 24, 25; Table 12-3
   effect, on bones    5.I.C, 5: notes 3, 5; 12.I.A.2; 12: note 5
      on ear    12.I.A.1, 12.I.A.2, 12.I.B.1, 12.I.B.2; 12: notes 4, 9; Table 12-1
      on eye    12.I.A.1, 12.I.A.2, 12.I.B.1, 12.I.B.2, 12.I.B.4, 12.I.C, 12.I.D, 12.I.E, 12.I.F; 12: notes 2, 14, 17; Tables 12-2, 12-3
      on pigment    12.I.A.1, 12.I.A.2, 12.I.B.1, 12.I.B.2, 12.I.B.4, 12.I.C, 12.I.D, 12.I.E, 12.I.F; 12: notes 1, 2, 7, 8, 9, 10, 11; Tables 12-1, 12-2, 12-3
      on tyrosinase activity    12.I.D.1; 12: notes 1, 13, 22, 23; Figure 12-1
      mutations at    12.I.A, 12.I.B, 12.I.C, 12.I.D, 12.I.E, 12.I.F; 12: note 26
      summary of pleiotropic effects    Table 12-3
Microphthalmia mice, choroid of    12.I.A.1, 12.I.A.2, 12.I.B.4; 12: note 2; Tables 12-1, 12-2
   cochlea of    5.III.C, 12: note 4
   ears of    12.I.A; 12: note 4
   eyes of    12.I.A, 12.I.B.2, 12.I.B.4; 12: notes 2, 4
   harderian gland of    12.I.A.1; Table 12-1
   iris of    12.I.A, 12.I.B.2; 12: note 2, 14, 17; Table 12-2
   melanocytes of    12.I.A.2
   melanosomes of    12.I.D.2
   osteopetrotic defect of    5.I.C; 5: notes 3, 5; 12.I.A.2; 12: note 5
   phenotypes of    12.I.A; 12: note 2; Table 12-3
   retina of    12.I.A.2, 12.I.B.2; 12: notes 17, 18; Table 12-2
   survival of    12.I.2; 12: note 5
   teeth of    12.I.A.2, 12.I.B.4
   vibrissae of    12.I.A.2, 12: note 16
   white spotting in    5.I.C, 12.I.A.1
Microphthalmia mutation (see also Microphthalmia locus)    12.I.A
   allelic interaction, with microphthalmia-Oak Ridge    12.I.F; Table 12-3
      with microphthalmia-spotted    12.I.D; Table 12-3
      with red-eyed white    12.I.F; Table 12-3
      with white    12: notes 13, 16, 18, 22, 24, 25; Tables 12-1, 12-2, 12-3
   effect, on osteogenesis    5.I.C; 5: notes 3, 5; 12.I.A.2; 12: note 5
      on phenotype    12.I.A; 12: note 2; Tables 12-1, 12-2, 12-3, 12-7
      on tyrosinase activity    12.D.1; 12: note 1
   origin of    12.I.A
   versus white    12.I.B.1, 12.I.B.2; 12: note 22
Microphthalmia-Oak Ridge mutation (see also Microphthalmia locus)    12.I.F; Table 12-3
Microphthalmia-spotted mice, eyes of    12.I.D
   hairs of    12.I.D.2
   melanosomes of    12.I.D.2; 12: notes 23, 24
   phenotype of    12.I.D; Table 12-3
Microphthalmia-spotted mutation (see also Microphthalmia locus)
   allelic interaction, with eyeless white    Table 12-3
      with microphthalmia    12.I.D; Table 12-3
      with red-eyed white    12.I.F; Table 12-3
      with white    12.I.D, 12.I.D.2; Table 12-3; 12: notes 16, 22, 24
   with wild-type    12.I.D; Table 12-3
   effect, on phenotype    12.I.D
   on tyrosinase activity    12.I.D.1; 12: notes 22, 23
   origin of    12.I.D
Microphthalmia-x mutation (see also Microphthalmia locus)    12.I.F; Table 12-3
Misty mutation    4: note 14; 5.VI.A, 6.IV.B
Mitotic rate, role in agouti patterns    2.I.E
Mocha mutation    Color Plate 2(G), 5.III; 5: note 6
"Modifier" mutation, interaction with chinchilla-mottled    3.II.B.7
Mo-locus (see Mottled locus)
Monotrichs    1.I; Figure 1-1
   of agouti mice    2.I.E; 2: note 7
   of agouti sombre mice    2.II.A.2
   of belted mice    9.IV.B
   of brindled mice    8.II.C.1, 8.II.C.2; Figure 8-4
   of tabby mice    8: note 5
   of viable yellow sombre mice    2.II.A.2
   of white-bellied agouti mice    2: note 7
Mosaic mutation (see also Mottled locus)     8.II.J.1
   effect, of copper chloride on expression of    8: note 18
      on hairs    8.II.J.1
      on phenotype    8.II.C.4, 8.II.J
      on vibrissae    8.II.J.1
   expression, in females    8.II.J.1; 8: note 18
      in males    8.II.J.1, 8: notes 18, 19
   interaction, with agouti    8.II.J.1
      with nonagouti    8.II.J.1
      with pink-eyed dilution    8.II.J.1
   maternal influence on expression of    8: notes 7, 18
   origin of    8.II.J
   selection for patterns produced by    8.II.C.4
Mottled agouti mutation (see also a-locus)    2.I.A.12
   and structure of a-locus    2.I.B
   effect on phenotype    2.I.A.12; 2: notes 8, 9; 4.II.C.8, 7.VI
   maternal influence on expression of    2: note 9
   origin of    2.I.A.12
   versus pink-eyed mottled    4.II.C.8
Mottled locus    8.II; Tables 8-1, 8-2, 8-3; Figures 8-2, 8-3, 8-4, 8-5, 8-6
   alleles at    8.II, 8.II.A, 8.II.B, 8.II.C, 8.II.D, 8.II.E, 8.II.F, 8.II.G, 8: notes 3, 6, 9, 12, 13, 14, 15, 16; Tables 8-2, 8-3
      action of    8.I
      interaction of    8.II.C.1, 8.II.E.1, 8.II.F.3, 8.II.G.3, 8.II.I; 8: note 13; Tables 8-1, 8-2, 8-3
   aortic lesions produced by    Table 8-1
   effect, on hairs    5: note 1; 8.II.H, 8.II.I
      on lysyl oxidase activity    8.II.I; 8: note 16
      on phenotype    Table 8-1, 8-2, 8-3; Figures 8-2, 8-3, 8-4, 8-5
      on viability    Table 8-3
   mutations at    8.II, 8.II.A, 8.II.B, 8.II.C, 8.II.D, 8.II.E, 8.II.F, 8.II.G; 8: notes 3, 12; Table 8-2
   rate of    Table 12-6
Mottled mutation (see also Mottled locus)    8.II.A, 8.II.C.2, 8.II.C.3, 8.II.H, 8: note 5; Tables 8-2, 8-3; Figure 8-1
MSH (see Melanocyte stimulating hormone)
Mus musculus    1; 2: note 6
Mus poschiavinus (see Tobacco-mouse)
Mutations, at a-locus    2.I.A, 2.I.B; 2: notes 11, 14; 5: note 13; 12.IV; 12: note 30; Table 12-5
   at b-locus    3.I.G, 3.I.H; 3: note 1; 12.IV; Table 12-5
   at c-locus    3.II.B.1, 3.II.B.2, 3.II.B.3, 3.II.B.5, 3.II.B.6, 3.II.B.7, 3.II.B.8; 3: notes 14, 16; 5: note 13; 12.IV; 12: notes 29, 30; Table 12-5
   at d-locus    3: note 15; 4.I.A; 4: notes 3, 6, 8; 12.IV; 12: note 30; Table 12-5
   at extension locus    2.II.A.1, 2.II.B, 2.II.C
   at leaden locus    4: note 1; 12.IV; Table 12-5
   at microphthalmia locus    12.I.A, 12.I.B, 12.I.C, 12.I.D, 12.I.E, 12.I.F; 12: note 26
   at mottled locus 8.II, 8.II.A.1, 8.II.C, 8.II.D, 8.II.E, 8.II.F, 8.II.G; 8: notes 3, 12; Tables 8-2, 12-6
   at pearl locus 5.VII.A, 5.VII.B
   at p-locus 4.II, 4.II.C; 4: notes 15, 16, 17, 18; 7.VI
   at ruby-eye locus 4.III
   at ruby-eye-2 locus 4.IV.A, 4.IV.B; 4: note 22
   at splotch locus 11.III, 11.III.B; 11: notes 27, 28; Table 12-6
   at steel locus 11.I, 11.I.C.1, 11.I.C.2, 11.I.C.3, 11.I.C.4, 11.I.C.5 11.I.C.6, 11.I.C.7; Table 12-6
   at W-locus 10.I, 10.I.B, 10.I.I.1, 10.I.I.2, 10.I.I.3, 10.I.I.4, 10.I.I.5, 10.I.I.6, 10.I.I.7, 10.I.I.8; 10: notes 1, 6, 29, 30, 32; Table 12-6
   in Ames dominant spotting mice 5: note 13
   in C57BL/6J strain 2: notes 14, 15; 11.I.C, 12.IV; Table 12-7
   in different mouse strains 12.IV; Table 12-7
   in white mice 5: note 13
   rates of 12.IV; 12: notes 29, 30, 31, 32 Tables 12-5, 12-6, 12-7
      at a-locus 12.IV; Table 12-5
      at b-locus 12.IV; Table 12-5
      at c-locus 12.IV; Table 12-5
      at d-locus 12.IV; 12: note 30; Table 12-5
      at leaden locus 12.IV; Table 12-5
      at mottled locus Table 12-6
      at splotch locus Table 12-6
      at steel locus Table 12-6
      at W-locus Table 12-6
   somatic 4.II.C.9; 4: notes 15, 17; 5.VII.B; 5: note 13; 7.VI; 10: note 7; 11.IV.B.1; 11: note 29; 12: note 32; Figure 7-5
   to ashen 6.IV.A
   to beige 6.I.A
   to belly spot 11: note 28
   to belly spot and tail 12.II.B
   to belted 9.IV; 9: note 15
   to belted-2 9: note 20
   to buff 6.IV.B
   to dark 2.III.B.3
   to dark footpads 6.IV.C
   to fleck Table 12-3
   to flexed-tailed 11.II
   to freckled 6.IV.E
   to grey-lethal 5.I.A
   to grizzled 5.II
   to gunmetal 6.IV.F
   to lethal spotting 9.III
   to light ear 6.IV.I
   to light (Li) 6.IV.G
   to mahoganoid 2.III.B.3
   to mahogany 2.III.B.2
   to misty 5.VI
   to mocha 5.III
   to muted 5.V
   to nonagouti curly 2.III.B.3
   to ochre 6.IV.H
   to pale ear 6.IV.I
   to pallid 5.IV
   to patch 10.II.A
   to patch-extended 10.II.B
   to pearl 5.VII
   to piebald 9.II.A.1; 9: note 6
   to piebald-lethal 9.II.B.1
   to recessive spotting 10: note 32
   to rump-white 10.II.C
   to sepia 6.IV.K
   to slaty 6.IV.L
   to taupe 6.IV.M
   to underwhite 6.IV.N
   to varitint-waddler 11.IV
   to varitint-waddler-J 11.IV, 11.IV.B
   to white underfur 6.IV.N
   X-linked 8.II, 8.II.A, 8.II.C, 8.II.D.1, 8.II.E, 8.II.F, 8.II.G, 8.III; 8: notes 3, 5; Tables 8-2, 12-6
Muted mutation 5.III.C, 5.V
Muzzle (see Nose)
"m(W)" complex 10.I.A.1, 10.I.A.2, 10.I.I.3; 10: note 3

Neural crest, defect of 5.IV.C, 9.II.G, 9.IV.C; 9: note 14; 10.I.F; 10: notes 16, 19; 11.III.A.2, 12.I.C.1
   in albino mice 3.II.A, 10.I.D; Figure 3-13
   in allophenic mice 7.III
   in black-eyed white mice 12.I.C.1
   in lethal spotting mice 9.III.C
   in piebald lethal mice 9.II.G
   in splotch mice 11.III.A.2
   in steel mice 11.I.B, 11.I.D
   in viable dominant spotting mice 10.I.D; 10: notes 16, 19
    migration of cells from 1.I; 1: notes 4, 5; 3.II.A, 7.I, 7.III, 9.I; 10: note 12; 11: notes 12, 13 Figure 3-13
    origin of 1.I; 1: note 4, 3.II.A
   origin of acoustic ganglion from 9: note 14; 10.I.F; 10: note 19
    origin of melanocytes from I.1, 1: notes 4, 5, 3.II.A; 5: note 8; 7.I, 7.III, 9.I; 10: notes 14, 19; Figure 3-13
Neural tube, grafts of 2.II.B.3, 3.II.A, 9.II.G; 9: notes 11, 13; 10.I.D; 10: note 16; 11.I.D; 11: note 11; Figure 3-13
   of splotch mice 11.III.A.1
Nictitans 10.I.E, 12.I.B.1
   effect of genotype on pigment of Table 10-1
Nipples (see mammae)
Nonagouti curly mutation 2.III.B.3; 2: note 45
Nonagouti lethal mutation (see also a-locus) 2.I.A.15; 2: note 10
Nonagouti mice, choroid of 3: note 5; 12: note 2; Table 9-1; Figures 6-2, 6-3
   ears of 2.I.A.10, 2.III.B.2; 2: note 13; 5.IV.B; 5: note 8; Table 2-2
   phenotypes of, Color Plates 1, 2, 3 2.I.A.10, 2.II.D; Figure 11-3
   effect, of MSH on 2.II.D, 2: notes 36, 37
      of sulfhydryls on 2.I.D
      of UV light on 2: note 23; 3: note 20
   eyes of 6.I.D; 12: note 2
   hair follicles of 2.I.E, 6.I.D; Figure 4-2
   hair of 2.I.A.10, 2.II.A.1, 6.I.B, 6.IV.I; Figures 4-1, 6-1
      number of melanocytes in 2.I.E; 2: note 23
   harderian gland of 6.I.D; Table 9-1; Figures 4-3, 4-4
   melanocytes of 2.I.E, 2: notes 22, 23, 25, 36; 3.I.G, 6.I.C, 6.I.D; Figures 3-4, 3-5, 3-6, 3-8, 3-9, 4-2, 4-3, 4-4, 4-5
   melanosomes of 2.I.C, 2.I.E; 3: notes 4, 5; 5.IV.B; 5: note 8; 6.I.D; Table 3-4; Figures 3-1, 3-3, 3-4, 3-5, 3-6, 3-8, 3-9, 4-1, 4-2, 4-3, 4-4, 4-5, 4-6, 4-8, 6-1, 6-2, 6-3
   phenotypes of, Color Plates 1, 2, 3 2.I.A, 2.III, Figure 11-3
   retina of 3: note 5, 5.IV.B; 5: note 8; Figure 6-2
Nonagouti mutation (see also a-locus) 2.I.A.10
   allelic interactions Table 2-2
      with agouti Table 2-2, 2.III.B
      with agouti umbrous 2.I.A.12, 2.I.A.13
      with intermediate agouti 2.I.A.7; Table 2-2
      with nonagouti lethal 2.I.A.15
   as umbrous gene 2.III.A
   behavior in transplants 2.I.E, 2.II.B.3; Tables 2-4, 2-5
   curly (see Nonagouti curly)
   effect, on melanosomes 2.I.C, 2.I.E, 2.I.F, 3.I.G, 3.II.D; 3: notes 4, 5; 5.IV.B; 5: note 8; 6.I.D; Tables 2-3, 3-1, 3-4; Figures 3-1, 3-3, 3-4, 3-5, 3-6, 3-8, 3-9, 4-1, 4-2, 4-3, 4-4, 4-5, 4-6, 4-8, 6-1, 6-2, 6-3
      on phenotype, Color Plates 1, 2, 3 2.I.A.10, 2.III; Figure 11-3
      on tyrosinase activity 2.I.C, 3.I.D, 3.II.E; Tables 3-1, 3-5
      on white spotting 12.III
   expression in allophenic mice 7.VI, 7.VII; 7: note 6; Figure 7-6
   extreme (see Extreme nonagouti)
   interaction, with beige, Color Plate 3(A); 6.I.B, 6.I.D; Figures 6-1, 6-2, 6-3
      with brown, Color Plates 1(F), 2(E); 2.I.A.10, 3.I.D, 3.II.D, 4.II.A, 4.II.B; Tables 3-1, 3-4; Figures 3-1, 4-4, 4-5, 6-3
      with buff 4.IV.B, 6.IV.B
      with chinchilla 3.II.B.2, 3.II.D, Tables 3-1, 3-2, 3-4, 3-5; Figure 4-6
      with dilute, Color Plate 2(E); 4.I.A, 4.I.B, 4.I.C, Figures 4-1, 4-2, 4-3, 4-5
      with extreme dilution 2.I.E, 3.II.B.1; Tables 3-2, 3-4
      with greying with age 6.III.B
      with grey-lethal 5.I
      with grizzled 5.II
      with himalayan, Color Plate 2(D); 3.II.B.6; Table 3-2
      with intense chinchilla 3.II.B.3; Table 3-2
      with leaden 4.I, 4.I.C; Figures 4-1, 4-2, 4-4, 4-5
      with light, Color Plate 1(H); 3.I.G; Figures 3-1, 3-2, 3-3, 3-4, 3-5, 3-6, 3-7, 3-8, 3-9
      with light ear 6.IV.I
      with mahogany 2.III.B.2
      with maroon 4.IV.B
      with misty 5.VI.A
      with mocha 5.III.A
      with mosaic 8.II.J
      with pale ear 6.IV.I
      with pallid, Color Plate 2(H)
      with pearl 5.VII
      with pink-eyed dilution, Color Plate 2(F); Figure 4-1, 4-2
      with platinum 3.II.B.5
      with ruby-eye 4.III.A
      with silver, Color Plate 3(B) 6.II.B, 6.II.C, 6.II.F
      with slaty 6.IV.L
      with steel, Color Plate 3(F)
      with taupe 6.IV.M
      with tobacco-darkening 2.II.B
      with tortoiseshell, Color Plate 3(C)
      with umbrous determinants 2.III.A, 2.III.B.1, 2.III.B.2
      with viable dominant spotting, Color Plate 3(D)
      with white, Color Plate 3(H); 12.I.B.1
   lethal (see Lethal nonagouti, Nonagouti lethal)
   linkage with mahogany 2: note 42
   maternal effect of 2: note 9
Nonagouti with dark agouti belly mutation (see also a-locus) 2.I.A.14
Nondisjunction 3: note 12; 10: note 7
Nose, of dilute mice 4.I.D
   of himalayan mice 3.II.B.6
   of leaden mice 4.I.D
   of pearl mice 5.VII
   of steel mice 11.I.A
Nucleofugal 3.I.G.1, 4.I.D, 4.I.E, 5.I.A; Figures 3-8, 4-3, 4-4, 4-5
Nucleopetal 3.I.G, 3.I.G.1, 4.I.D, 4.I.E, 5.I.A; 5: note 1; Figures 3-8, 4-3, 4-4, 4-5

Obesity, absence in recessive yellow mice 2.II.C.2
   in intermediate yellow mice 2.I.A.3; 2: note 5
   in lethal yellow mice 2.I.A.1, 2.II.A.2, 2.II.C.2, 2: note 28
   in lethal yellow sombre mice 2: note 28
   in viable yellow mice 2.I.A.2, 2.II.A.2; 2: note 5
Ochre mutation 6.IV.H
Opisthotonus 4.I.A; 4: note 8
Organ of Corti, of microphthalmia mice 12: note 4
   of mocha mice 5.IV.C
   of varitint-waddler mice 11: note 31
   of viable dominant spotting mice 10.I.F
Osteopetrosis, in grey-lethal mice 5.I.B, 5.I.C; 5: notes 3, 5; 12.I.A.2, 12: note 5
   in microphthalmia mice 5: notes 3, 5; 12.I.A.2; 12: note 5
   in osteopetrosis mice 5: note 5
   in osteosclerotic mice 5: note 5
   in rats 5.I.C
Osteopetrosis mutation 5: note 5
Osteosclerotic mutation 5: note 5
Otoliths, of mocha mice 5.III.C    of muted mice 5.III.C, 5.V.A, 5.V.B
   of ochre mice 6.IV.H
   of pallid mice 5.IV.A, 5.IV.C, 5.IV.D; 5: notes 10, 11
Ovary, of contrasted mice 11.I.C.3; 11: note 9
   of normal (C57BL) mice 10: note 24
   of p-black-eyed sterile mice 4: note 19
   of pink-eyed dilution mice 4: note 19
   of pink-eyed unstable mice 4: note 19
   of p6H mice 4: note 19
   of p25H mice 4: note 19
   of viable dominant spotting mice 10.I.H, 10.I.H.1; 10: notes 24, 26
   transplantation of 10.I.H.1; 10: notes 24, 26; 11: note 26

Pale ear mutation 6.IV.I; 6: note 11
Pallid mice, behavior of 5.III.B, 5.IV, 5.IV.A, 5.IV.C, 5.IV.D; 5: note 10; 6.IV.H
   ears of 5.III.C, 5.IV.A, 5.IV.C, 5.IV.D; 5: notes 10, 11
   eyes of 4.III, 5.IV.A, 5.IV.B, 5.IV.C
   melanocytes of 5.IV.A, 5.IV.B, 5.IV.D; 5: note 8
   melanosomes of 5.IV.B, 5.IV.D; 5: note 8
   phenotypes of, Color Plate 2(H); 5.IV.A, 5.IV.B, 5.IV.C
Pallid mutation 5.IV, 5.IV.A, 5.IV.B, 5.IV.C, 5.IV.D
   effect, of manganese on expression of 5.IV.D; 5: notes 10, 19
      on behavior 5.III.B, 5.III.C, 5.IV, 5.IV.A, 5.IV.C, 5.IV.D; 5: note 10; 6.IV.H
      on lysosomal enzymes 6: note 11
      on melanosomes 5.IV.B, 5.IV.D; 5: note 7
      on otoliths 5.III.C, 5.IV.C, 5.IV.D; 5: notes 10, 11
      on phenotype, Color Plate 2(H); 5.IV, 5.IV.A, 5.IV.B, 5.IV.C
      on size 5: note 9
   interaction, with agouti 5.IV.A
      with albinism 5.IV.D
      with brown 5.IV.B, 5.IV.D
      with lethal yellow 5.IV.A
      with nonagouti, Color Plate 2(H)
      with pink-eyed dilution 5.IV.A
      with viable dominant spotting 5.IV.A, 5.IV.D
   linkage with agouti suppressor 2: note 10
   origin of 5.IV.A
Panda-white mutation (see also W-locus) 10.I.I.5; Table 10-2
Parathyroid 5.I.C; 12: note 5
Patch-extended mutation 10.II.B; 10: note 35; Figure 10-6
Patch mice, hair follicles of 10.II.D
   melanocytes of 10.II.D
   phenotypes of 10.II, 10.II.A; Figures 10-3, 10-4, 10-5
   skin of 10.II.A.5, 10.II.D, 10: notes 37, 38
Patch mutation 10.II
   action of 10.II.D; 10: notes 33, 34, 36, 37, 38
   allelic interaction with patch-extended 10.II.B
   effect, on erythropoiesis 10.II.A.6
      on gametogenesis 10.II.A.6; 10: note 34
      on phenotype 10.II, 10.II.A; Figures 10-3, 10-4, 10-5
      when homozygous 10.II.A.4, 10.II.A.5; 10: note 33
   extended (see Patch-extended)
   interaction, with belted 10.II.A.1
      with dominant spotting 10.II.A.2; Figure 10-4
      with lethal yellow 12: note 28
      with piebald 10.II.A.2
      with recessive yellow 12: note 28
      with rump-white 10.II.A.2; Figure 10-4
      with sash 10.I.I.6
      with steel 10.II.A.2
      with steel-Dickie 10.II.A.2; Figure 10-4
      with viable dominant spotting 10.II.A.1, 10.II.A.2; Figures 10-4, 10-5
      with white 10.II.A.1, 10.II.A.2, 10.II.C.3
   linkage, with rump-white 10.II
      with sash 10.I.I.6
      with viable dominant spotting 10.II
   origin of 10.II.A
   versus rump-white 10.II.C.1, 10.II.D; 10: notes 37, 38
Paws (see Feet)
p-black-eyed sterile mutation (see also p-locus) 4.II.C, 4.II.C.6, 4.II.C.7; 4: note 19; Table 4-1
p-cleft palate (see also p-locus) 4.II.C, 4.II.C.6, 4.II.C.7; Table 4-1
p-darkening (see also p-locus) 4.II.C, 4.II.C.7; Table 4-1
Pearl mutation 5.VII; 5: notes 12, 13; 6.IV.D; 6: note 11
Pelage (see Hair)
Perineum (see Genital papilla)
PET strain 4: note 10
Pewter mutation 8.II, 8.III
p-extra dark mutation (see also p-locus) 4.II.C, 4.II.C.7; Table 4-1
Phaeomelanin 2.I
   association with obesity 2.I.A.2, 2.II.A.2; 2: note 5
   attributes of melanosomes of 2.I.C; Table 2-3; Figures 2-2, 2-3
   biosynthesis of 2.I.C, 2.I.D, 2.I.E; 2: note 18; Figure 2-4
   effect, of a-locus on 2.I; Table 2-3
      of b-locus on 3.I.A, 3.I.G, 3.I.G.1
      of c-locus on 3.II.B.1, 3.II.B.2, 3.II.B.3, 3.II.B.4, 3.II.B.5, 3.II.C, 3.II.D; 3: note 17
      of dermis on 2.I.E
      of d-locus on 2: note 33; 3.I.G.1, 4.I, 4.I.B, 4.I.C; 4: note 9; Figure 4-3
      of epidermis on 2.I.E
      of extension locus on 2.II, 2.II.A, 2.II.C.2, 2.II.C.3; 2: note 17
      of leaden locus on 2.II.C.2, 3.I.G.1, 4.I, 4.I.C
      of MSH on 2.II.D, 2: notes 36, 37, 38
      of sulfhydryls on 2.I.D
      of umbrous determinants on 2.III; 2: notes 40, 45
      on white spotting 12.III, 12: note 28
   extraction of 2.I.C, 2.II.C.2
   in agouti mice 2.I.A.5, 2.I.C, 2.I.D, 2.I.E; 2: notes 21, 24; Tables 2-3, 2-4
   in beige mice 6.I.B, 6.I.C; 6: note 6
   in grey-lethal mice 5.I.A, 5.II; 5: note 2
   in grizzled mice 5.II
   in lethal yellow mice 2.I.C, 2.I.D, 2.I.E; 2: notes 28, 33, 37; Table 2-4
   in mocha mice 5.III
   in muted mice 5.V
   in pallid mice 5.IV.A
   in pink-eyed dilute mice 3.I.G, 3.II.B.2, 4.II.A, 4.II.D
   in recessive yellow mice 2.II.C, 5: note 2
   in ruby-eyed mice 4.III.A
   in ruby-eye-2 mice 4.IV.A
   tyrosinase activity of 2.I.C, 2.I.D; 2: notes 18, 19; 3.I.D, 3.II.E; Table 3-1
   ultrastructure of melanosomes of 2.I.C; Figures 2-2, 2-3
   versus eumelanin 2.I, 2.I.B, 2.I.C; 2: notes 13, 18, 19, 20, 21, 24; 3.I.C, 3.II.D; Tables 2-2, 2-3, 3-1, 3-4; Figures 2-2, 2-3, 2-4
Phaeomelanin granules (see Melanosomes, Phaeomelanin)
Phenoclones 7.VI, 8.I
   in blotchy mice 8.II.F, 8.II.H
   in brindled mice 8.II.H
   in dappled mice 8.II.E.2, 8.II.H
   in pink-eyed unstable mice 7.VI; Figure 7-5
   in tabby mice 8.II.C.4; 8: note 5
   in tortoiseshell mice 8.II.G.1, 8.II.I
   in viable-brindled mice 8.II.D, 8.II.H
   in viable yellow mice 2: note 4; 7.VI; Figure 7-6
Phenocopy 2.II.A.1
   of pallid 5.IV.D
Phenylalanine 4.I.A, 4.I.C; 4: note 5; 8: note 19
Phenylalanine hydroxylase (see Phenylalanine)
Piebald-lethal mice, cochlea of 5.III.C, 9.II.B.3
   ears of 5.III.C, 9.II.B.3; 9: note 14
   megacolon in 9.II.A.3, 9.II.B.2, 9.II.G, 9.III.A; 9: note 5
   phenotypes of 9.II.B; Figure 9-2
   survival of 9.II.B.1; 9: note 5
Piebald-lethal mutation 9.II.B; Figure 9-2
   action of 9.II.G; 9: note 14
   allelic interaction with piebald 9: note 5
   effect on phenotype 9.II.B; Figure 9-2
   interaction, with lethal yellow 12.III
      with recessive yellow 12.III
      with W-fertile 10.I.I.3
   origin of 9.II.B
Piebald mice, choroid of 9.II.A.2; 9: notes 3, 4; Tables 9-1, 12-1, 12-2
   ears of 9.II.A.2; Tables 9-1, 12-1
   eyes of 9.II.A.2; 9: notes 3, 4; Tables 12-1, 12-2
   hair follicles of Figure 3-10
   harderian gland of 9.II.A.2, 9.II.G; Tables 9-1, 12-1
   leg muscles of 9.II.G; 9: notes 16, 17
   megacolon in 9.II.A.3, 9.II.B.2, 9.II.G, 9.III; 9: note 5
   melanocytes of 9.II.A.2; 9: notes 11, 13, 14
   phenotypes of Color Plate 2(E) 9.II.A.2, 9.II.A.3, 9.II.D, 9.II.E, 9.II.G; 9: notes 2, 3, 4, 8, 12; Tables 12-1, 12-2; Figure 9-3
   skin of 9.II.G; 9: notes 11, 13; Table 9-1
Piebald mutation 9.I, 9.II.A, 9.II.B, 9.II.C, 9.II.D, 9.II.E, 10.II.A.2
   action of 9.II.G; 9: notes 11, 13
   allelic interaction with piebald-lethal 9: note 5
   effect on phenotype Color Plate 2(E) 9.II.A.2, 9.II.A.3, 9.II.D, 9.II.G, 9: notes 2, 3, 4, 5, 12; Tables 12-1, 12-2; Figure 9-3
   interaction, with beige 6.I.C
      with brindled 8: note 10
      with dappled 8.II.E.3
      with dominant spotting 10.I.A.2, 10.II.A.2; 10: note 5; 12.III
      with "k" complex 9.II.D; 9: note 8
      with lethal yellow 12.III
      with "m(W)" complex 10.I.A.1, 10.I.A.2
      with patch 10.II.A.2
      with recessive yellow 12.III
      with rump-white 10.II.C.3
      with tortoiseshell 8.II.G.1
      with varitint-waddler 11.IV.A.3
      with viable brindled 8: note 9
   linkage, with freckled 6.IV.E
      with slaty 6.IV.L
   origin of 9.II.A.1
   similarity to lethal spotting 9.III.A
Piebald (pb) mutation 9: note 6
Pigment, black (see Eumelanin)
   brown (see Brown, Eumelanin)
   yellow (see Phaeomelanin)
Pigment granules (see Eumelanin, Melanosomes, Phaeomelanin)
Pigment cells (see Melanocytes)
Pigmentation lag, in dilute mice 4.I.C
   in leaden mice 4.I.C
   in microphthalmia-spotted mice 12.I.D.2
   in pink-eyed dilution mice 4.II.D
   in white mice 12.I.B.1, 12.I.D.2
Pink-eyed dilution mice, effect of MSH on 2.II.D
   eyes of 4.II, 4.II.A, 4.II.E, 6.I.C; Table 4-1
   hair follicles of 3.II.A, 4.II.E; Figure 4-2
   hair of 4.II.A, 4.II.D, 6.I.C; Figures 4-1, 4-6
   melanocytes of 3.I.G, 3.I.G.1, 4.II.E; Figure 4-2
   melanosomes of 3.II.G, 4.II.D, 4.II.E, 6.I.C, 6.I.E; 6: note 8; Figures 4-1, 4-2, 4-6, 4-7
   phenotypes of, Color Plate 2(F) 3.II.C, 4.II.A, 4.II.B, Tables 3-2, 4-1; Figure 4-5
Pink-eyed dilution mutation (see also p-locus), action of 4.II.C.3, 4.II.C.7, 4.II.E; 4: notes 19, 21
    allelic interaction, with dark pink-eye 4.II.C.7; Table 4-1
      with p-black-eyed sterile 4.II.C.5; Table 4-1
      with p-cleft palate 4.II.C.6
      with p-extra dark Table 4-1
      with pink-eyed mottled 4.II.C.8
      with wild-type 3.I.G, 3.I.G.1; 3: note 8; 4.II.B
   effect, on eumelanin 3.I.G.1, 3.II.B.4, 3.II.G, 4.II, 4.II.D, 4.II.E; Figures 4-6, 4-7
      on melanosomes 3.II.G, 4.I.C, 6.I.C, 6.I.E; 6: note 8; Figures 4-6, 4-7
      on phaeomelanin 3.I.G, 3.II.B.4, 4.II.A, 4.II.E
      on phenotype Color Plate 2(F) 3.II.C, 4.II.A, 4.II.B, Tables 3-2, 4-1; Figure 4-5
      on reproductive system 4: notes 18, 19
      on tyrosinase activity 3.II.E, 4.II.E; 4: note 21; Table 3-5
   interaction, with agouti 4.II.A
      with albinism 3.II.C
      with beige 6.I.C, 6.I.E; 6: note 8
      with black-eyed white 12.I.C
      with brown 3.I.B, 3.II.G, 4.II.B, 4.II.D
      with chinchilla 3.II.B.4; Tables 3-2, 3-5; Figure 3-12
      with dilute 3.I.G.1; Figure 4-2
      with extreme dilution Table 3-2
      with intense chinchilla 3.II.B.4; Table 3-2
      with leaden 3.I.G.1; Figure 4-1
      with lethal yellow 4.II.A, 4.II.D
      with light 3.I.G, 3.I.G.1; 3: note 8; 4.II.B
      with mosaic 8.II.J
      with nonagouti Color Plate 2(F); 4.II.A, 4.II.E, Figures 4-1, 4-2, 4-5, 4-6
      with pallid 5.IV.A
      with ruby-eye 4.IV.A
      with white-bellied agouti Figure 3-12
   linkage with c-locus 4.II.C.3; 4: note 13
Pink-eyed mottled-1 mutation (see also p-locus) 4.II.C, 4.II.C.8; 4: note 15; 7.VI
Pink-eyed mottled-2 mutation (see also p-locus) 4.II.C, 4.II.C.8; 4: note 15; 7.VI
Pink-eyed sterile mutation (see also p-locus) 4.II.C, 4.II.C.3
Pink-eyed unstable mutation (see also p-locus) 4.II.C, 4.II.C.9, 4.II.E; 4: notes 16, 18, 19; 7.VI
   effect, on eyes 4: note 16
      on phenotype 4.II.C.9, 7.VI
      on reproductive system 4: notes 16, 19
   interaction with belted 12: note 28
   similarity to pearl 5: note 13
Pituitary, of p-black-eyed sterile mice 4: note 19
   of pink-eyed dilution mice 4: note 19
   of pink-eyed unstable mice 4: note 19
   of p6H mice 4: note 19
   of p25H mice 4: note 19
   of viable dominant spotting mice 10: note 24
Plantar skin (see also Feet), of agouti mice 2: note 23
   of dilute mice 4.I.D; 4: note 12
   of himalayan mice 3: note 20
   of leaden mice 4.I.D
   of lethal yellow mice 2: note 23
   of light mice 3.I.G.1
   UV light induced tanning of 3: note 20
Platino mutation 6: note 18
Platinum mutation (see also c-locus) Color Plate 2(C) 3.II.B.5, 3: notes 13, 21
Pleiotropism (see Pleiotropic effects)
Pleiotropic effects 1, 5.IV.D
   of flexed-tailed 11.II, 11.II.A, 11.II.B; 11: notes 20, 21, 22, 23
   of lethal yellow 2.I.A
   of microphthalmia locus alleles Table 12-3
   of p-locus alleles 4.II.C.3, 4.II.C.5, 4.II.C.6, 4.II.E; 4: note 19
   of steel locus alleles Table 11-1
   of varitint-waddler 11.IV.A.1, 11.IV.A.4, 11.IV.B.1
   of viable yellow 2.I.A.2
   of w-locus alleles Table 10-2
p-locus 4.II
   alleles at 4.II, 4.II.C.1, 4.II.C.2, 4.II.C.3, 4.II.C.4, 4.II.C.5, 4.II.C.6, 4.II.C.7, 4.II.C.8, 4.II.C.9
      action of 4.II.C.3, 4.II.C.8, 4.II.E; 4: note 19
      interaction of 3.I.G, 3.I.G.1; 3: note 8; 4.II.B, 4.II.C.5; Table 4-1
   effect, on melanosomes 3.II.G, 4.I.C, 4.II.D, 4.II.E, 6.I.C, 6.I.E, 6: note 8; Figures 4-2, 4-6, 4-7
      on reproductive system 4: note 19
   interaction, with black-eyed white 12.I.C
      with b-locus 3.I.B, 3.I.G, 3.I.G.1, 3.II.G; 3: note 8; 4.II.A, 4.II.B; Figure 4-5
      with c-locus 3.II.C; Table 3-2, 3-5
   linkage with c-locus 4.II.C.3, 4: note 13
   pleiotropic effects of 4.II.C.3, 4.II.C.5, 4.II.C.6, 4.II.E; 4: note 19
p6H mutation (see also p-locus) 4.II.C, 4.II.C.4; 4: note 19; Table 4-1
P25H mutation (see also p-locus) 4.II.C, 4.II.C.4, 4: note 19; Table 4-1
Position effect 4.II.C.8
   in agouti suppressor mice 2.I.A.17
   in a6H mice 2: note 11
   in flecked mice 7: note 1
Premelanosomes (see Melanosomes)
Pseudoalleles 2.I.B; 2: note 12
Previous   Next


A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   R   S   T   U   V   W   X   Y   Z